Genesys International Corporation Limited Announces Statutory Auditor Firm Conversion to LLP Structure

1 min read     Updated on 16 Jan 2026, 05:24 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Genesys International Corporation Limited has announced that its statutory auditors M S K A & Associates, Chartered Accountants have converted to M S K A & Associates LLP under the Limited Liability Partnership Act, 2008. The company confirmed this structural change does not affect the existing audit engagement, and the LLP will continue statutory audit obligations for the remaining appointment period.

30110054

*this image is generated using AI for illustrative purposes only.

Genesys International Corporation Limited has notified stock exchanges regarding a structural change in its statutory auditor firm under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company announced that its statutory auditors have converted their firm structure to a Limited Liability Partnership.

Auditor Firm Conversion Details

The statutory auditors M S K A & Associates, Chartered Accountants have converted their firm into a Limited Liability Partnership under the provisions of the Limited Liability Partnership Act, 2008. Following this conversion, the firm now operates under the name M S K A & Associates LLP, Chartered Accountants.

Parameter: Details
Previous Firm Name: M S K A & Associates, Chartered Accountants
New Firm Name: M S K A & Associates LLP, Chartered Accountants
Conversion Act: Limited Liability Partnership Act, 2008
Regulatory Framework: SEBI Regulation 30

Continuity of Audit Engagement

Genesys International Corporation Limited has confirmed that the conversion does not result in any changes to the existing audit engagement. M S K A & Associates LLP will continue to function and discharge their obligations as statutory auditors for the remaining period of their appointment tenure.

The company has formally communicated this development to both BSE Limited and National Stock Exchange of India Limited for record purposes. Company Secretary and Compliance Officer Kushal Jain signed the intimation letter dated January 16, 2026, ensuring compliance with regulatory disclosure requirements.

Regulatory Compliance

This announcement fulfills the company's obligation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of material events and information to stock exchanges.

Historical Stock Returns for Genesys International Corp

1 Day5 Days1 Month6 Months1 Year5 Years
-3.73%-20.76%-17.15%-47.79%-64.69%+341.79%
Genesys International Corp
View in Depthredirect
like17
dislike

Genesys International Corporation Limited Allots 20,165 Equity Shares Under ESOP Scheme 2020

1 min read     Updated on 13 Jan 2026, 05:59 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Genesys International Corporation Limited allotted 20,165 equity shares under its ESOP Scheme 2020 on January 13, 2026, following approval by the Nomination and Remuneration Committee. The allotment to eligible employees increased the company's paid-up capital to ₹20,89,51,885, comprising 4,17,90,377 equity shares of ₹5.00 face value each. The newly issued shares rank pari passu with existing equity shares.

29852987

*this image is generated using AI for illustrative purposes only.

Genesys International Corporation Limited has announced the allotment of 20,165 equity shares under its Employee Stock Option Plan (ESOP) Scheme 2020. The Nomination and Remuneration Committee approved this allotment through a resolution passed by circulation on January 13, 2026.

Share Allotment Details

The allotment pertains to eligible employees who exercised their stock options under the Genesys ESOP Scheme 2020. Each share carries a face value of ₹5.00, representing the company's commitment to employee participation in its growth.

Parameter: Details
Shares Allotted: 20,165 equity shares
Face Value: ₹5.00 per share
Scheme: Genesys ESOP Scheme 2020
Approval Date: January 13, 2026
Approval Method: Resolution by Circulation

Impact on Share Capital

Following this allotment, the company's capital structure has been updated to reflect the increased shareholding. The paid-up capital has risen to ₹20,89,51,885, demonstrating the company's expanding equity base through employee participation.

Capital Structure: Post-Allotment
Paid-up Capital: ₹20,89,51,885.00
Total Equity Shares: 4,17,90,377 shares
Face Value per Share: ₹5.00

Share Rights and Compliance

The newly allotted shares will rank pari passu with the existing equity shares of the company in all respects, ensuring equal rights for all shareholders. The company has informed both BSE Limited and National Stock Exchange of India Limited about this corporate action, maintaining transparency with regulatory authorities and market participants.

The allotment was communicated to the stock exchanges through Company Secretary and Compliance Officer Kushal Jain, ensuring proper regulatory compliance and record maintenance.

Historical Stock Returns for Genesys International Corp

1 Day5 Days1 Month6 Months1 Year5 Years
-3.73%-20.76%-17.15%-47.79%-64.69%+341.79%
Genesys International Corp
View in Depthredirect
like16
dislike
More News on Genesys International Corp
Explore Other Articles
343.05
-13.30
(-3.73%)